Development of chronic pain in males with traumatic spinal cord injury: role of circulating levels of the chemokines CCL2 and CXCL10 in subacute stage

[1]  V. Tillmann,et al.  Changes in inflammatory markers in estonian pubertal boys with different BMI values and increments: A 3‐Year Follow‐Up Study , 2017, Obesity.

[2]  A. Oliviero,et al.  Early spermatogenesis changes in traumatic complete spinal cord-injured adult patients , 2017, Spinal Cord.

[3]  W. Waring,et al.  Updates for the International Standards for Neurological Classification of Spinal Cord Injury. , 2014, Physical medicine and rehabilitation clinics of North America.

[4]  T. Hibi,et al.  Suppressive effects of interleukin-18 on liver function in rat liver allografts. , 2012, The Journal of surgical research.

[5]  Ralf Baron,et al.  Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms , 2012, Neuron.

[6]  E. Donadi,et al.  Evaluation of Serum Levels of Chemokines during Interferon-β Treatment in Multiple Sclerosis Patients , 2011, CNS drugs.

[7]  Juliette van Steenwinckel,et al.  CCL2 Released from Neuronal Synaptic Vesicles in the Spinal Cord Is a Major Mediator of Local Inflammation and Pain after Peripheral Nerve Injury , 2011, The Journal of Neuroscience.

[8]  M. Soroush,et al.  Chronic pain after spinal cord injury: results of a long-term study. , 2010, Pain medicine.

[9]  Y. Koninck,et al.  Chemokines and pain mechanisms , 2009, Brain Research Reviews.

[10]  W. Rostène,et al.  Chemokine Action in the Nervous System , 2008, The Journal of Neuroscience.

[11]  Michael G Fehlings,et al.  Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. , 2008, Neurosurgical focus.

[12]  H. Boddeke,et al.  Neuron-microglia signaling: Chemokines as versatile messengers , 2008, Journal of Neuroimmunology.

[13]  W. Rostène,et al.  Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist‐treated rats , 2008, Journal of neurochemistry.

[14]  K. Biber,et al.  Region‐specific expression of immunoregulatory proteins on microglia in the healthy CNS , 2008, Glia.

[15]  R. Ji,et al.  Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord , 2008, The Journal of Neuroscience.

[16]  R. Ransohoff,et al.  Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses , 2007, Neuroscience.

[17]  R. LaMotte,et al.  MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. , 2006, Journal of neurophysiology.

[18]  Ralf Baron,et al.  Mechanisms of Disease: neuropathic pain—a clinical perspective , 2006, Nature Clinical Practice Neurology.

[19]  P. Scherle,et al.  Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344 , 2005, The Journal of Immunology.

[20]  C. Abbadie.  Chemokines, chemokine receptors and pain. , 2005, Trends in immunology.

[21]  J. Eng,et al.  Pain following spinal cord injury: the impact on community reintegration , 2005, Spinal Cord.

[22]  R. Ji,et al.  Cell Signaling and the Genesis of Neuropathic Pain , 2004, Science's STKE.

[23]  C. Sommer,et al.  Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia , 2004, Neuroscience Letters.

[24]  L. Sorkin,et al.  Increased Sensitivity of Injured and Adjacent Uninjured Rat Primary Sensory Neurons to Exogenous Tumor Necrosis Factor-α after Spinal Nerve Ligation , 2003, The Journal of Neuroscience.

[25]  C. Woolf,et al.  Can we conquer pain? , 2002, Nature Neuroscience.

[26]  Bonica Jj.  History of pain concepts and pain therapy. , 1991 .

[27]  F. Gao,et al.  Spinal IFN-γ-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models , 2013, Breast Cancer Research and Treatment.

[28]  E. Ferrannini,et al.  CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. , 2008, Rheumatology.

[29]  V. Dietz,et al.  Functional outcome following spinal cord injury: significance of motor-evoked potentials and ASIA scores. , 1998, Archives of physical medicine and rehabilitation.

[30]  J. Bonica.  History of pain concepts and pain therapy. , 1991, The Mount Sinai journal of medicine, New York.